Cargando…
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low five-year survival rates leading to a substantial worldwide burden for healthcare systems. HCC initiation and progression are favored by different etiological risk factors including hepatitis B virus (HBV) a...
Autores principales: | Tümen, Deniz, Heumann, Philipp, Gülow, Karsten, Demirci, Cagla-Nur, Cosma, Lidia-Sabina, Müller, Martina, Kandulski, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775527/ https://www.ncbi.nlm.nih.gov/pubmed/36551958 http://dx.doi.org/10.3390/biomedicines10123202 |
Ejemplares similares
-
Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma
por: Michalski, Marlen, et al.
Publicado: (2023) -
Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches
por: Cosma, Lidia-Sabina, et al.
Publicado: (2022) -
HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022) -
The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway
por: Gülow, Karsten, et al.
Publicado: (2023) -
Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose
por: Allgaier, Raphael, et al.
Publicado: (2023)